Diagnosis, prevention and treatment of haemodialysis catheter-related bloodstream infections (CRBSI): A position statement of European Renal Best Practice (ERBP)

NDT Plus

Volumn 3, Issue 3, 2010, Pages 234-246

  Vanholder, Raymond ^a   Canaud, Bernard ^b   Fluck, Richard ^c   Jadoul, Michel ^d   Labriola, Laura ^d   Marti Monros, A ^e   Tordoir, J ^f   Van Biesen, W ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

^b LAPEYRONIE HOSPITAL   (France)

^c ROYAL DERBY HOSPITAL   (United Kingdom)

^d CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^e HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^f MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; CEFAZOLIN; CEFTAZIDIME; DAPTOMYCIN; ECHINOCANDIN; GENTAMICIN; MINOCYCLINE; PLACEBO; POLYSPORIN; PSEUDOMONIC ACID; TEICOPLANIN; TOBRAMYCIN; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; BLOOD CULTURE; CATHETER INFECTION; DIALYSIS CATHETER; DRUG EFFICACY; HEMODIALYSIS; HUMAN; INTRAVENOUS CATHETER; NONHUMAN; NURSING CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW;

EID: 77952994713     PISSN: 17530784     EISSN: 17530792     Source Type: Journal    
DOI: 10.1093/ndtplus/sfq041     Document Type: Review

References (82)

1. Mermel LA, Allon M, Bouza E et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis 2009; 49: 1-45
2. Zoccali C, Abramowicz D, Cannata-Andia JB et al. European best practice quo vadis? From European Best Practice Guidelines (EBPG) to European Renal Best Practice (ERBP). Nephrol Dial Transplant 2008; 23: 2162-2166
3. Vanholder R, Abramowicz D, Cannata-Andia JB et al. The future of European nephrology guidelines-a declaration of intent by European renal Best Practice (ERBP). NDT Plus 2009; 2: 213-221. Ref Type: Generic
4. Locatelli F, Covic A, Eckardt KU, Wiecek A, Vanholder R. Anaemia management in patients with chronic kidney disease: a position statement by the Anaemia Working Group of European Renal Best Practice (ERBP). Nephrol Dial Transplant 2009; 24: 348-354
5. Covic A, Abramowicz D, Bruchfeld A et al. Endorsement of the Kidney Disease Improving Global Outcomes (KDIGO) hepatitis C guidelines: a European Renal Best Practice (ERBP) position statement. Nephrol Dial Transplant 2009; 24: 719-727
6. Haemodialysis-associated infection. Nephrol Dial Transplant 2002; 17: 73-87
7. Tordoir J, Canaud B, Haage P et al. EBPG on vascular access. Nephrol Dial Transplant 2007; 22: ii88-ii117
8. Guyatt GH, Oxman AD, Vist GE et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336: 924-926
9. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int 2009; 76: S1-130
10. Ethier J, Mendelssohn DC, Elder SJ et al. Vascular access use and outcomes: an international perspective from the Dialysis Outcomes and Practice Patterns Study. Nephrol Dial Transplant 2008; 23: 3219-3226
11. Lemaire X, Morena M, Leray-Moragues H et al. Analysis of risk factors for catheter-related bacteremia in 2000 permanent dual catheters for hemodialysis. Blood Purif 2009; 28: 21-28
12. Oliver MJ, Callery SM, Thorpe KE, Schwab SJ, Churchill DN. Risk of bacteremia from temporary hemodialysis catheters by site of insertion and duration of use: a prospective study. Kidney Int 2000; 58: 2543-2545
13. Ranasinghe JS, Lee AJ, Birnbach DJ. Infection associated with central venous or epidural catheters: how to reduce it? Curr Opin Anaesthesiol 2008; 21: 386-390
14. http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5110a1.htm
15. Pronovost P, Needham D, Berenholtz S et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med 2006; 355: 2725-2732
16. McLure HA, Talboys CA, Yentis SM, Azadian BS. Surgical face masks and downward dispersal of bacteria. Anaesthesia 1998; 53: 624-626
17. Droste JC, Jeraj HA, MacDonald A, Farrington K. Stability and in vitro efficacy of antibiotic-heparin lock solutions potentially useful for treatment of central venous catheter-related sepsis. J Antimicrob Chemother 2003; 51: 849-855
18. Regamey C, Schaberg D, Kirby WM. Inhibitory effect of heparin on gentamicin concentrations in blood. Antimicrob Agents Chemother 1972; 1: 329-332
19. Shanks RM, Sargent JL, Martinez RM, Graber ML, OToole GA. Catheter lock solutions influence staphylococcal biofilm formation on abiotic surfaces. Nephrol Dial Transplant 2006; 21: 2247-2255
20. Yahav D, Rozen-Zvi B, Gafter-Gvili A, Leibovici L, Gafter U, Paul M. Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials. Clin Infect Dis 2008; 47: 83-93
21. Labriola L, Crott R, Jadoul M. Preventing haemodialysis catheterrelated bacteraemiawith an antimicrobial lock solution: a meta-analysis of prospective randomized trials. Nephrol Dial Transplant 2008; 23: 1666-1672
22. Winnett G, Nolan J, Miller M, Ashman N. Trisodium citrate 46.7% selectively and safely reduces staphylococcal catheter-related bacteraemia. Nephrol Dial Transplant 2008; 23: 3592-3598
23. Allon M. Prophylaxis against dialysis catheter-related bacteremia with a novel antimicrobial lock solution. Clin Infect Dis 2003; 36: 1539-1544
24. Weijmer MC, van den Dorpel MA, van de Ven PJG et al. Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in hemodialysis patients. J Am Soc Nephrol 2005; 16: 2769-2777
25. Lok CE, Appleton D, Bhola C, Khoo B, Richardson RM. Trisodium citrate 4%-an alternative to heparin capping of haemodialysis catheters. Nephrol Dial Transplant 2007; 22: 477-483
26. Betjes MG, van Agteren M. Prevention of dialysis catheter-related sepsis with a citrate-taurolidine-containing lock solution. Nephrol Dial Transplant 2004; 19: 1546-1551
27. Grudzinski L, Quinan P, Kwok S, Pierratos A. Sodium citrate 4% locking solution for central venous dialysis catheters-an effective, more cost-efficient alternative to heparin. Nephrol Dial Transplant 2007; 22: 471-476
28. MacRae JM, Dojcinovic I, Djurdjev O et al. Citrate 4% versus heparin and the reduction of thrombosis study (CHARTS). Clin J Am Soc Nephrol 2008; 3: 369-374
29. Polaschegg HD, Sodemann K. Safety of concentrated trisodium citrate catheter locks. Nephrol Dial Transplant 2008; 23: 4075-4076
30. Soriano A, Bregada E, Marques JM et al. Decreasing gradient of antibiotic concentration in the lumen of catheters locked with vancomycin. Eur J Clin Microbiol Infect Dis 2007; 26: 659-661
31. http://www.pslgroup.com/dg/1CD1AE.htm
32. Moran JE, Ash SR. Locking solutions for hemodialysis catheters; heparin and citrate-a position paper by ASDIN. Semin Dial 2008; 21: 490-492
33. Willicombe MK, Vernon K, Davenport A. Embolic complications from central venous hemodialysis catheters used with hypertonic citrate locking solution. Am J Kidney Dis 2010; 55: 348-351
34. Landry D, Sweet S, Gobeille S, Haessler SD, Vaidya CK, Braden G. Long-term gentamycin lock catheter prophylaxis is associated with gentamycin-resistant gram-positive bacteremias in chronic hemodialysis patients http://www.abstracts2view.com/asn (abstract 2009)
35. Onland W, Shin CE, Fustar S, Rushing T, Wong WY. Ethanol-lock technique for persistent bacteremia of long-term intravascular devices in pediatric patients. Arch Pediatr Adolesc Med 2006; 160: 1049-1053
36. Broom J, Woods M, Allworth A et al. Ethanol lock therapy to treat tunnelled central venous catheter-associated blood stream infections: results from a prospective trial. Scand J Infect Dis 2008; 40: 399-406
37. Balestrino D, Souweine B, Charbonnel N et al. Eradication of microorganisms embedded in biofilm by an ethanol-based catheter lock solution. Nephrol Dial Transplant 2009; 24: 3204-3209
38. Takla TA, Zelenitsky SA, Vercaigne LM. Effectiveness of a 30% ethanol/4% trisodium citrate locking solution in preventing biofilm formation by organisms causing haemodialysis catheter-related infections. J Antimicrob Chemother 2008; 62: 1024-1026
39. Bleyer AJ, Mason L, Russell G, Raad II, Sherertz RJ. A randomized, controlled trial of a new vascular catheter flush solution (minocycline-EDTA) in temporary hemodialysis access. Infect Control Hosp Epidemiol 2005; 26: 520-524
40. Dwyer A. Surface-treated catheters a review. Semin Dial 2008; 21: 542-546
41. Verbeke F, Haug U, Dhondt A et al. The role of polymer surface degradation and barium sulphate release in the pathogenesis of catheterrelated infection. Nephrol Dial Transplant 2010; 25: 1207-1213
42. Trerotola SO, Johnson MS, Shah H et al. Tunneled hemodialysis catheters: use of a silver-coated catheter for prevention of infection-a randomized study. Radiology 1998; 207: 491-496
43. Bambauer R, Mestres P, Schiel R, Bambauer S, Sioshansi P, Latza R. Long-term catheters for apheresis and dialysis with surface treatment with infection resistance and low thrombogenicity. Ther Apher Dial 2003; 7: 225-231
44. Beathard GA, Urbanes A. Infection associated with tunneled hemodialysis catheters. Semin Dial 2008; 21: 528-538
45. Hoffmann KK, Weber DJ, Samsa GP, Rutala WA. Transparent polyurethane film as an intravenous catheter dressing. A meta-analysis of the infection risks. JAMA 1992; 267: 2072-2076
46. Gillies D, ORiordan L, Carr D, Frost J, Gunning R, OBrien I. Gauze and tape and transparent polyurethane dressings for central venous catheters. Cochrane Database Syst Rev 2003; CD003827
47. Rabindranath KS, Bansal T, Adams J et al. Systematic review of antimicrobials for the prevention of haemodialysis catheter-related infections. Nephrol Dial Transplant 2009; 24: 3763-3774
48. James MT, Conley J, Tonelli M, Manns BJ, MacRae J, Hemmelgarn BR. Meta-analysis: antibiotics for prophylaxis against hemodialysis catheter-related infections. Ann Intern Med 2008; 148: 596-605
49. Tacconelli E, Carmeli Y, Aizer A, Ferreira G, Foreman MG, DAgata EM. Mupirocin prophylaxis to prevent Staphylococcus aureus infection in patients undergoing dialysis: a meta-analysis. Clin Infect Dis 2003; 37: 1629-1638
50. Zakrzewska-Bode A, Muytjens HL, Liem KD, Hoogkamp-Korstanje JA. Mupirocin resistance in coagulase-negative staphylococci, after topical prophylaxis for the reduction of colonization of central venous catheters. J Hosp Infect 1995; 31: 189-193
51. Miller MA, Dascal A, Portnoy J, Mendelson J. Development of mupirocin resistance among methicillin-resistant Staphylococcus aureus after widespread use of nasal mupirocin ointment. Infect Control Hosp Epidemiol 1996; 17: 811-813
52. Perez-Fontan M, Rosales M, Rodriguez-Carmona A, Falcon TG, Valdes F. Mupirocin resistance after long-term use for Staphylococcus aureus colonization in patients undergoing chronic peritoneal dialysis. Am J Kidney Dis 2002; 39: 337-341
53. Maki DG, Band JD. A comparative study of polyantibiotic and iodophor ointments in prevention of vascular catheter-related infection. Am J Med 1981; 70: 739-744
54. Chu KH, Choy WY, Cheung CC, Richardson R, Tobe SW, Conly J. A prospective study of the efficacy of local application of gentamicin versus mupirocin in the prevention of peritoneal dialysis catheter-related infections. Perit Dial Int 2008; 28: 505-508
55. Bernardini J, Bender F, Florio T, Navaneethan SD, Craig JC, Strippoli GF. Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients. J Am Soc Nephrol 2005; 16: 539-545
56. Johnson DW, van Eps C, Mudge DW, Schena FP, Craig JC. Randomized, controlled trial of topical exit-site application of honey (Medihoney) versus mupirocin for the prevention of catheter-associated infections in hemodialysis patients. J Am Soc Nephrol 2005; 16: 1456-1462
57. Lok CE, Stanley KE, Hux JE, Richardson R, Tobe SW, Conly J. Hemodialysis infection prevention with polysporin ointment. J Am Soc Nephrol 2003; 14: 169-179
58. Bonifati C, Pansini F, Torres DD, Navaneethan SD, Craig JC, Strippoli GF. Antimicrobial agents and catheter-related interventions to prevent peritonitis in peritoneal dialysis: using evidence in the context of clinical practice. Int J Artif Organs 2006; 29: 41-49
59. Strippoli GF, Tong A, Johnson D, Schena FP, Craig JC. Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients. Cochrane Database Syst Rev 2004; CD004679
60. Perez-Fontan M, Rosales M, Rodriguez-Carmona A et al. Treatment of Staphylococcus aureus nasal carriers in CAPD with mupirocin. Adv Perit Dial 1992; 8: 242-245
61. Maki DG, Weise CE, Sarafin HW. A semiquantitative culture method for identifying intravenous-catheter-related infection. N Engl J Med 1977; 296: 1305-1309
62. Bouza E, Alvarado N, Alcala L et al. A prospective, randomized, and comparative study of 3 different methods for the diagnosis of intravascular catheter colonization. Clin Infect Dis 2005; 40: 1096-1100
63. Park KH, Kim SH, Song EH et al. Development of bacteraemia or fungaemia after removal of colonized central venous catheters in patients with negative concomitant blood cultures. Clin Microbiol Infect 2009
64. Bouza E, Alvarado N, Perez MJ, Rincon C, Muñoz P. A randomized and prospective study of 3 procedures for the diagnosis of catheterrelated bloodstream infection without catheter withdrawal. Clin Infect Dis 2007; 44: 820-826
65. Safdar N, Fine JP, Maki DG. Meta-analysis: methods for diagnosing intravascular device-related bloodstream infection. Ann Intern Med 2005; 142: 451-466
66. Gaur AH, Flynn PM, Heine DJ, Giannini MA, Shenep JL, Hayden RT. Diagnosis of catheter-related bloodstream infections among pediatric oncology patients lacking a peripheral culture, using differential time to detection. Pediatr Infect Dis J 2005; 24: 445-449
67. Raad I, Hanna HA, Alakech B, Chatzinikolaou I, Johnson MM, Tarrand J. Differential time to positivity: a useful method for diagnosing catheter-related bloodstream infections. Ann Intern Med 2004; 140: 18-25
68. Allon M. Treatment guidelines for dialysis catheter-related bacteremia: an update. Am J Kidney Dis 2009; 54: 13-17
69. Reddy AS, Lang EV, Cutts J, Loh S, Rosen MP. Fibrin sheath removal from central venous catheters: an internal snare manoeuvre. Nephrol Dial Transplant 2007; 22: 1762-1765
70. Kite P, Dobbins BM, Wilcox MH et al. Evaluation of a novel endoluminal brush method for in situ diagnosis of catheter related sepsis. J Clin Pathol 1997; 50: 278-282
71. Raad I, Hanna H, Maki D. Intravascular catheter-related infections: advances in diagnosis, prevention, and management. Lancet Infect Dis 2007; 7: 645-657
72. Fortun J, Grill F, Martin-Davila P et al. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy. J Antimicrob Chemother 2006; 58: 816-821
73. Onder AM, Chandar J, Simon N et al. Comparison of tissue plasminogen activator-antibiotic locks with heparin-antibiotic locks in children with catheter-related bacteraemia. Nephrol Dial Transplant 2008; 23: 2604-2610
74. Ashby DR, Power A, Singh S et al. Bacteremia associated with tunneled hemodialysis catheters: outcome after attempted salvage. Clin J Am Soc Nephrol 2009; 4: 1601-1605
75. Stryjewski ME, Szczech LA, Benjamin DK Jr, et al. Use of vancomycin or first-generation cephalosporins for the treatment of hemodialysisdependent patients with methicillin-susceptible Staphylococcus aureus bacteremia. Clin Infect Dis 2007; 44: 190-196
76. Sakoulas G, Moise-Broder PA, Schentag J, Forrest A, Moellering RC Jr, Eliopoulos GM. Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resis-tant Staphylococcus aureus bacteremia. J Clin Microbiol 2004; 42: 2398-2402
77. Kuhn DM, George T, Chandra J, Mukherjee PK, Ghannoum MA. Antifungal susceptibility of Candida biofilms: unique efficacy of amphotericin B lipid formulations and echinocandins. Antimicrob Agents Chemother 2002; 46: 1773-1780
78. Ruhe J, Menon A, Mushatt D, Dejace P, Hasbun R. Non-epidermidis coagulase-negative staphylococcal bacteremia: clinical predictors of true bacteremia. Eur J Clin Microbiol Infect Dis 2004; 23: 495-498
79. Kielstein JT, Lorenzen J, Kaever Vet al. Risk of underdosing of ampicillin/sulbactam in patients with acute kidney injury undergoing extended daily dialysis-a single case. Nephrol Dial Transplant 2009; 24: 2283-2285
80. Kropec A, Huebner J, Wursthorn M, Daschner FD. In vitro activity of vancomycin and teicoplanin against Staphylococcus aureus and Staphylococcus epidermidis colonizing catheters. Eur J Clin Microbiol Infect Dis 1993; 12: 545-548
81. Maya ID, Carlton D, Estrada E, Allon M. Treatment of dialysis catheter-related Staphylococcus aureus bacteremia with an antibiotic lock: a quality improvement report. Am J Kidney Dis 2007; 50: 289-295
82. Peterson WJ, Maya ID, Carlton D, Estrada E, Allon M. Treatment of dialysis catheter-related Enterococcus bacteremia with an antibiotic lock: a quality improvement report. Am J Kidney Dis 2009; 53: 107-111